{
      "Rank": 1,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Stempeucel - CLI will be administered at the lowest dose",
            "Stempeucel - CLI will be administered at intermediate dose",
            "Standard protocol of care alone"
      ],
      "ArmGroupInterventionName": [
            "Biological: Allogeneic Mesenchymal Stem Cells",
            "Biological: Allogeneic Mesenchymal Stem Cells"
      ],
      "ArmGroupLabel": [
            "Low dose",
            "Intermediate dose",
            "Control arm"
      ],
      "ArmGroupType": [
            "Experimental",
            "Experimental",
            "No Intervention"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT01484574"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "This is an open label, non-randomized, dose ranging study to evaluate the safety and efficacy of different doses of Stempeucel in critical limb ischemia patients."
      ],
      "BriefTitle": [
            "A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "March 2016"
      ],
      "CompletionDateType": [
            "Actual"
      ],
      "Condition": [
            "Critical Limb Ischemia",
            "Buerger's Disease"
      ],
      "ConditionAncestorId": [
            "D000010335",
            "D000001157",
            "D000014652",
            "D000002318",
            "D000014657"
      ],
      "ConditionAncestorTerm": [
            "Pathologic Processes",
            "Arterial Occlusive Diseases",
            "Vascular Diseases",
            "Cardiovascular Diseases",
            "Vasculitis"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC23",
            "All",
            "BC14",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Symptoms and General Pathology",
            "All Conditions",
            "Heart and Blood Diseases",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Ischemia",
            "Buerger's Disease",
            "Buerger's Disease"
      ],
      "ConditionBrowseLeafId": [
            "M9695",
            "M15830",
            "M3617",
            "M16552",
            "M16557",
            "T889"
      ],
      "ConditionBrowseLeafName": [
            "Ischemia",
            "Thromboangiitis Obliterans",
            "Arterial Occlusive Diseases",
            "Vascular Diseases",
            "Vasculitis",
            "Buerger Disease"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "low",
            "low",
            "low",
            "high"
      ],
      "ConditionMeshId": [
            "D000013919",
            "D000007511"
      ],
      "ConditionMeshTerm": [
            "Thromboangiitis Obliterans",
            "Ischemia"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Non-Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nBuerger's disease as diagnosed by Shionoya criteria\nMales or females (willing to use accepted methods of contraception during the course of the study) in the age group of 18-65 yrs\nEstablished CLI in the study limb, clinically and hemodynamically confirmed as per Rutherford- III-5\nPatients in Rutherford- III-6 if gangrene extending maximally up to the head of metatarsal but limited to toes (Patients with wet gangrene must undergo wound debridement / amputation before screening)\nPatients having infrapopliteal occlusive disease with rest pain and ischemic ulcer/necrosis, who are not eligible for or have failed traditional revascularization treatment as per the investigators judgment (No option patients)\nAnkle Brachial Pressure Index (ABPI) \u2264 0.6 or ankle pressure \u2264 50 mm Hg or TcPO2 \u2264 40 mmHg in the foot of the study limb\nPatients who are able to understand the requirements of the study, and willing to provide voluntary written informed consent and video consent, abide by the study requirements, and agree to return for required follow-up visits\n\nExclusion Criteria:\n\nPatients with CLI indicated for major amputation during screening\nAtherosclerotic PAD\nUlcers with exposure of tendon and/bone in the shin region\nPrevious above transmetatarsal amputation in study limb\nAny Lumbar sympathectomy procedure performed less than 90 days prior to the screening\nPatients with gait disturbance for reasons other than CLI\nDiagnosis of diabetes mellitus (type 1 or type 2)\nPatients having left ventricular ejection fraction < 35%\nPatients suffering from clinically relevant peripheral neuropathy\nHistory of Stroke or myocardial infarction\nPatients who are contraindicated for MRA\nPatients with deep vein thrombosis in any limb\nPatients who have clinically serious and/or unstable inter-current infection, medical illnesses or conditions that are uncontrolled or whose control, in the opinion of the Investigator, may be jeopardized by participation in this study or by the complications of this therapy\nDocumented terminal illness or cancer or any concomitant disease process with a life expectancy of <1 year\nPatients already enrolled in another investigational drug trial or completed within 3 months or those who have participated in any stem cell clinical trial\nPatient with known hypersensitivity to the constituents of the IMP - dimethyl sulfoxide (DMSO) or human serum albumin (HSA)\nHistory of severe alcohol or drug abuse within 3 months of screening\nHb% < 10 gm% for males, Hb% < 9 gm% for females, serum creatinine \u2265 2mg%, serum Total Bilirubin \u22652mg%\nPregnant and lactating women\nPatients tested positive for HIV 1, HCV, HBV, CMV, RPR"
      ],
      "EnrollmentCount": [
            "90"
      ],
      "EnrollmentType": [
            "Actual"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Low dose",
            "Intermediate dose"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Single intramuscular administration of low dose of stem cells",
            "Single intramuscular administration of intermediate dose of stem cells"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Allogeneic Mesenchymal Stem Cells",
            "Allogeneic Mesenchymal Stem Cells"
      ],
      "InterventionOtherName": [
            "Stempeucel - CLI",
            "Stempeucel - CLI"
      ],
      "InterventionType": [
            "Biological",
            "Biological"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Critical limb ischemia",
            "Buerger's disease",
            "Critical limb ischemia due to Buerger's disease"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "September 13, 2016"
      ],
      "LastUpdatePostDateType": [
            "Estimate"
      ],
      "LastUpdateSubmitDate": [
            "September 12, 2016"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Stempeutics Research Pvt Ltd"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "New Delhi",
            "Gurgaon",
            "Bangalore",
            "Bangalore",
            "Mangalore",
            "Chennai",
            "Chennai",
            "Chennai",
            "Kolkata",
            "Kolkata"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "India",
            "India",
            "India",
            "India",
            "India",
            "India",
            "India",
            "India",
            "India",
            "India"
      ],
      "LocationFacility": [
            "Department of Surgical Disciplines, All India Institute of Medical Sciences",
            "Division of Peripheral Vascular and Endovascular Sciences, Medanta - The Medicity",
            "Department of Vascular and Endovascular Surgery, M. S. Ramaiah Medical College and Hospitals",
            "Peripheral Vascular Surgery, Sri Jayadeva Institute of Cardiovascular Sciences & Research",
            "Department of Surgery, KMC, Mangalore",
            "Department of Vascular Surgery, Madras Medical College",
            "Department of Vascular Surgery, Sri Ramchandra Medical College",
            "Department of Vascular Surgery, Stanley Medical College",
            "Department of Vascular Surgery, AMRI Hospital",
            "Nightingale Hospital"
      ],
      "LocationState": [
            "Delhi",
            "Haryana",
            "Karnataka",
            "Karnataka",
            "Karnataka",
            "Tamil Nadu",
            "Tamil Nadu",
            "Tamil Nadu",
            "West Bengal",
            "West Bengal"
      ],
      "LocationStatus": [],
      "LocationZip": [
            "110029",
            "122001",
            "560066",
            "560069",
            "575001",
            "600003",
            "600116",
            "91-44-24732266",
            "700029",
            "700071"
      ],
      "MaximumAge": [
            "65 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "A Non-randomized, Open Label, Multicentric, Dose Ranging , Phase II Study Assessing the Efficacy and Safety of Intramuscular Administration of Stempeucel - CLI\u2122 (ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells) in Patients With Critical Limb Ischemia Due to Buerger's Disease"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Stempeutics Research Pvt Ltd"
      ],
      "OrgStudyId": [
            "SRPL/CLI/10-11/001"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "AMRI Hospital",
            "All India Institute of Medical Sciences, New Delhi",
            "Stanley Medical College",
            "Sri Ramchandra Medical College",
            "Madras Medical College",
            "KMC, Mangalore",
            "M. S. Ramaiah Medical College",
            "Medanta - The Medicity",
            "Nightingale Hospital",
            "Sri Jayadeva Institute of Cardiovascular Sciences & Research"
      ],
      "OverallOfficialName": [
            "Dr Anirban Chatterjee",
            "Dr Anita Dhar",
            "Dr Rajkumar M",
            "Dr Radhakrishnan R",
            "Dr Vidyasagaran T",
            "Dr Alfred Augustine",
            "Dr Sanjay Desai",
            "Dr Rajiv Parakh",
            "Dr Santanu Dutta",
            "Dr Murali Krishna"
      ],
      "OverallOfficialRole": [
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Completed"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "February 2014"
      ],
      "PrimaryCompletionDateType": [
            "Actual"
      ],
      "PrimaryOutcomeDescription": [
            "Rest pain will be measured using rest pain scale (0 to10)",
            "Complete ulcer healing defined as complete epithelisation of ulcer and partial ulcer healing as at least 30% decrease in ulcer size.",
            "Rest pain will be measured using rest pain scale (0 to 10)",
            "Complete ulcer healing defined as complete epithelisation of ulcer and partial ulcer healing as at least 30% decrease in ulcer size."
      ],
      "PrimaryOutcomeMeasure": [
            "Relief of the rest pain",
            "Healing of ulcerations or reduction of ulcer area in the target limb",
            "Relief of the rest pain",
            "Healing of ulcerations or reduction of ulcer area in the target limb"
      ],
      "PrimaryOutcomeTimeFrame": [
            "6 months",
            "6 months",
            "24 months",
            "24 months"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [],
      "SecondaryOutcomeMeasure": [
            "Pain free walking distance",
            "Major amputation free survival",
            "Ankle brachial pressure index (ABPI) - measured by Doppler",
            "Increase in transcutaneous partial oxygen pressure (TcPO2)",
            "Quality of life by King's College VascuQOL questionnaire",
            "Angiogenesis - collateral blood vessels by Magnetic resonance angiogram (MRA)",
            "The type of adverse events AE(s), number of AE(s) and proportion of patients with AE(s).",
            "Assessment of clinical laboratory parameters",
            "Physical examination findings and assessment of vital signs",
            "Assessment of electrocardiogram (ECG) parameters"
      ],
      "SecondaryOutcomeTimeFrame": [
            "6 and 24 months",
            "6 and 24 months",
            "6 and 24 months",
            "6 and 24 months",
            "6 and 24 months",
            "6 and 24 months",
            "6 and 24 months",
            "6 and 24 months",
            "6 and 24 months",
            "6 and 24 months"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "January 2012"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "September 2016"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "December 2, 2011"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "November 27, 2011"
      ],
      "StudyFirstSubmitQCDate": [
            "December 1, 2011"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 07, 2022"
      ],
      "WhyStopped": []
}